Patents by Inventor Richard Allen Rosenbloom

Richard Allen Rosenbloom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7914823
    Abstract: A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect. In addition, the topical compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment.
    Type: Grant
    Filed: February 19, 2003
    Date of Patent: March 29, 2011
    Assignee: Prophase Labs, Inc.
    Inventor: Richard Allen Rosenbloom
  • Patent number: 7507425
    Abstract: A method for treatment of cachexia and or alleviating one or more symptoms of cachexia involving the step of administering, to a human or animal, a composition including ingredients obtainable from turmeric, ginger, green tea, and, optionally, horseradish. This composition may further include a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: September 26, 2006
    Date of Patent: March 24, 2009
    Assignee: The Quigley Corporation
    Inventor: Richard Allen Rosenbloom
  • Patent number: 7405046
    Abstract: Methods for prophylactic and anti-transmissivity uses of an anti-microbial composition are disclosed. The methods comprise the step of administering to a mammal or a bird, an amount of a composition having a first ingredient obtainable from ginger; a second ingredient obtainable from green tea; an optional third ingredient obtainable from turmeric; and an acceptable carrier. When administered the composition is effective to reduce the incidence of contracting an illness or to prophylactically prevent transmission of an illness. Also disclosed are nasal and throat spray compositions for use in the methods of the invention.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: July 29, 2008
    Assignee: The Quigley Corporation
    Inventor: Richard Allen Rosenbloom
  • Patent number: 6753325
    Abstract: A composition for the preventing, reducing or treating radiation dermatitis includes a mixture of one or more compounds that regulates cell differentiation and/or cell proliferation, and one or more antioxidants formulated in a pharmaceutically acceptable carrier. The composition of the present invention may further include a flavonoid. A method for the topical administration of the composition in accordance with the present invention for the purpose of preventing, reducing or treating radiation dermatitis involves topically administering an effective amount of the composition of the invention an area of skin which has been or will be exposed to radiation. The composition and method can be employed to prevent, reduce or treat radiation dermatitis caused by a wide variety of types of radiation exposure and is particularly useful for the prevention, reduction or treatment of radiation recall dermatitis.
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: June 22, 2004
    Assignee: The Quigley Corporation
    Inventor: Richard Allen Rosenbloom
  • Publication number: 20030138504
    Abstract: A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect. In addition, the topical compositions of the present invention, when used in effective amounts to treat diabetic neuropathy, do not exhibit the severe side effects of many prior art compositions proposed for treatment of this ailment.
    Type: Application
    Filed: February 19, 2003
    Publication date: July 24, 2003
    Inventor: Richard Allen Rosenbloom
  • Patent number: 6592896
    Abstract: A novel composition for treating symptoms such as symptoms of a common cold, a sore throat, congestion, laryngitis, mucous membrane inflammation and sialorrhea is disclosed. The composition includes ingredients to obtainable from turmeric extract, ginger root powder, and horseradish root powder. This composition can be orally administered a patient. The composition may further include ingredients obtainable from slippery elm bark powder and green tea. This composition may further include a pharmaceutically acceptable carrier for oral administration. A method of administering this composition orally to a patient to treat symptoms of a common cold, a sore throat, congestion, laryngitis, mucositis, sialorrhea and mucous membrane inflammation is also disclosed. To treat these symptoms, the composition is administered to a patient suffering one to fifteen times daily, as needed. To achieve the best effect, the composition should be held in the mouth of a patient for 5 to 60 minutes.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: July 15, 2003
    Assignee: The Quigley Corporation
    Inventor: Richard Allen Rosenbloom
  • Publication number: 20030103953
    Abstract: A composition for the preventing, reducing or treating radiation dermatitis includes a mixture of one or more compounds that regulates cell differentiation and/or cell proliferation, and one or more antioxidants formulated in a pharmaceutically acceptable carrier. The composition of the present invention may further include a flavonoid. A method for the topical administration of the composition in accordance with the present invention for the purpose of preventing, reducing or treating radiation dermatitis involves topically administering an effective amount of the composition of the invention an area of skin which has been or will be exposed to radiation. The composition and method can be employed to prevent, reduce or treat radiation dermatitis caused by a wide variety of types of radiation exposure and is particularly useful for the prevention, reduction or treatment of radiation recall dermatitis.
    Type: Application
    Filed: November 6, 2001
    Publication date: June 5, 2003
    Inventor: Richard Allen Rosenbloom
  • Patent number: 6555573
    Abstract: A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: April 29, 2003
    Assignee: The Quigley Corporation
    Inventor: Richard Allen Rosenbloom
  • Publication number: 20030031737
    Abstract: A novel composition for treating symptoms such as symptoms of a common cold, a sore throat, congestion, laryngitis, mucous membrane inflammation and sialorrhea is disclosed. The composition includes ingredients to obtainable from turmeric extract, ginger root powder, and horseradish root powder. This composition can be orally administered a patient. The composition may further include ingredients obtainable from slippery elm bark powder and green tea. This composition may further include a pharmaceutically acceptable carrier for oral administration.
    Type: Application
    Filed: August 6, 2001
    Publication date: February 13, 2003
    Inventor: Richard Allen Rosenbloom
  • Publication number: 20020115618
    Abstract: A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect.
    Type: Application
    Filed: December 21, 2000
    Publication date: August 22, 2002
    Inventor: Richard Allen Rosenbloom